BL
NVS icon

BCWM LLC’s Novartis NVS Stock Holding History

BCWM LLC’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37,744
Closed -$3.45M – 68
2019
Q2 		$3.45M Sell
37,744
-3,763
-9% -$318K 1.38% 32
2019
Q1 		$3.58M Buy
41,507
+237
+0.6% +$19K 1.61% 30
2018
Q4 		$31.7M Sell
41,270
-1,132
-3% -$88.1K 1.51% 32
2018
Q3 		$3.22M Buy
42,402
+236
+0.6% +$17.4K 1.35% 35
2018
Q2 		$2.85M Buy
42,166
+1,711
+4% +$118K 1.25% 36
2018
Q1 		$2.93M Buy
40,455
+676
+2% +$51.5K 1.25% 40
2017
Q4 		$2.99M Buy
39,779
+604
+2% +$45.6K 1.22% 43
2017
Q3 		$3.01M Buy
39,175
+175
+0.4% +$13.2K 1.26% 39
2017
Q2 		$2.92M Sell
39,000
-2,238
-5% -$159K 1.3% 38
2017
Q1 		$2.74M Sell
41,238
-221
-0.5% -$14.7K 1.24% 41
2016
Q4 		$2.71M Sell
41,459
-369
-0.9% -$23.9K 1.26% 37
2016
Q3 		$2.96M Buy
41,828
+85
+0.2% +$6.19K 1.38% 37
2016
Q2 		$3.09M Buy
41,743
+762
+2% +$52.6K 1.48% 37
2016
Q1 		$2.66M Buy
+40,981
New +$2.79M 1.48% 34

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

BCWM LLC's NVS Position: Q3 2019 in Review

BCWM LLC sold out of Novartis (NVS) in Q3 2019, closing a stake of 37,744 shares — an estimated $3.45M sold.

BCWM LLC first reported a position in NVS in Q1 2016 and held it in 14 quarters. The position peaked at $31.7M in Q4 2018. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

  • BCWM LLC reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
  • BCWM LLC sold 37,744 Novartis shares in Q3 2019, an estimated $3.45M.
  • BCWM LLC first reported a position in Novartis in Q1 2016 and held it in 14 quarters.
  • BCWM LLC's Novartis position peaked at $31.7M in Q4 2018.
  • 1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on BCWM LLC's 13F filing for Q3 2019, filed 13 Nov 2019.